Sep 25, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 25, 2017 -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it has...
Griffin Capital Securities Completes Channelization of Sales Organization
Sep 25, 2017 12:01 pm UTC| Business
EL SEGUNDO, Calif., Sept. 25, 2017 -- Griffin Capital Company, LLC (“Griffin Capital”) announced today that Griffin Capital Securities, LLC (“GCS”), Griffin Capital’s captive broker-dealer and distributor, completed a...
Atossa Genetics Announces Upcoming Phase 2 Study of Topical Endoxifen
Sep 25, 2017 12:01 pm UTC| Business
SEATTLE, Sept. 25, 2017 -- Atossa Genetics Inc. (NASDAQ:ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions has contracted with...
Sep 25, 2017 12:01 pm UTC| Business
Protocol has been adjusted according to EMA Scientific AdviceFiling in Europe will be done in the coming days PARIS, Sept. 25, 2017 -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in...
Inuvo to Present at Upcoming Investor Conferences
Sep 25, 2017 12:01 pm UTC| Business
LITTLE ROCK, Ark., Sept. 25, 2017 -- Inuvo, Inc. (NYSE MKT:INUV), a global advertising technology company, today announced that the Company is scheduled to present at two upcoming investor conferences. Mr. Wally Ruiz,...
Sep 25, 2017 12:01 pm UTC| Business
BUFFALO, N.Y., Sept. 25, 2017 -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related...
Sep 25, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 25, 2017 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), today announced that its collaborator ISU Abxis has completed dosing of the first subcutaneous cohort (N = 3, the second of up to...